Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases.
1985
A randomized, double-blind trial on the effects of GM1 ganglioside in cerebrovascular diseases was done on 40 patients; the treatment (40 mg/day i.m. injection) began after the acute phase
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
41
Citations
NaN
KQI